|
|
|
|
|
by frostirosti
1718 days ago
|
|
> do not want to be vaccinated
What's the reason for this? The vaccine has been approved fully by the FDA and hundreds of millions of people have received it. > 2. ...
Sure, and people who have had covid and get it again as well. But why risk sick days, lost productivity, severe illness when there's an effective, safe alternative.
The capital cost of caring people who get sick with covid is far higher on a per capita basis for those who are unvaccinated. |
|
It's none of your business why they don't want to be vaccinated. If science demonstrates that COVID survivors have strong immunity, why should they be forced to be vaccinated as well? We do not force people who can show immunity to measles, mumps, and rubella to get the MMR vaccine.
From the CDC: https://www.cdc.gov/vaccines/vpd/mmr/public/index.html
> You do not need measles, mumps, and rubella (MMR) vaccine if you meet any of these criteria for presumptive evidence of immunity*:
> You have laboratory confirmation of past infection or had blood tests that show you are immune to measles, mumps, and rubella.
> Sure, and people who have had covid and get it again as well. But why risk sick days, lost productivity, severe illness when there's an effective, safe alternative. The capital cost of caring people who get sick with covid is far higher on a per capita basis for those who are unvaccinated.
You are distorting the science by trying to lump people who survived COVID in with the unvaccinated. They are not the same group.
From Israel: https://www.medrxiv.org/content/10.1101/2021.08.24.21262415v...
> SARS-CoV-2-naïve vaccinees had a 13.06-fold (95% CI, 8.08 to 21.11) increased risk for breakthrough infection with the Delta variant compared to those previously infected, when the first event (infection or vaccination) occurred during January and February of 2021. The increased risk was significant (P<0.001) for symptomatic disease as well. When allowing the infection to occur at any time before vaccination (from March 2020 to February 2021), evidence of waning natural immunity was demonstrated, though SARS-CoV-2 naïve vaccinees had a 5.96-fold (95% CI, 4.85 to 7.33) increased risk for breakthrough infection and a 7.13-fold (95% CI, 5.51 to 9.21) increased risk for symptomatic disease. SARS-CoV-2-naïve vaccinees were also at a greater risk for COVID-19-related-hospitalizations compared to those that were previously infected.
> This study demonstrated that natural immunity confers longer lasting and stronger protection against infection, symptomatic disease and hospitalization caused by the Delta variant of SARS-CoV-2, compared to the BNT162b2 two-dose vaccine-induced immunity. Individuals who were both previously infected with SARS-CoV-2 and given a single dose of the vaccine gained additional protection against the Delta variant.